BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24002146)

  • 21. Oral foreign body granuloma: unusual presentation of a rare adverse reaction to permanent injectable cosmetic filler.
    da Costa Miguel MC; Nonaka CF; dos Santos JN; Germano AR; de Souza LB
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):385-7. PubMed ID: 19243914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler.
    Yutskovskaya Y; Kogan E; Leshunov E
    J Drugs Dermatol; 2014 Sep; 13(9):1047-52. PubMed ID: 25226004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in Nasal Sensibility Following Calcium Hydroxyapatite Dorsal Augmentation.
    Alharethy S
    J Craniofac Surg; 2018 Mar; 29(2):e104-e106. PubMed ID: 29068971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiance.
    Flaharty P
    Facial Plast Surg; 2004 May; 20(2):165-9. PubMed ID: 15643585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.
    Marmur E; Green L; Busso M
    Dermatol Surg; 2010 Mar; 36(3):309-15. PubMed ID: 20100272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results.
    Jacovella PF
    Clin Plast Surg; 2006 Oct; 33(4):511-23. PubMed ID: 17085220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications from Nasolabial Fold Injection of Calcium Hydroxylapatite for Facial Soft-Tissue Augmentation: A Systematic Review and Meta-Analysis.
    Shi XH; Zhou X; Zhang YM; Lei ZY; Liu T; Fan DL
    Aesthet Surg J; 2016 Jun; 36(6):712-7. PubMed ID: 27178901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds.
    Smith S; Busso M; McClaren M; Bass LS
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S112-21; discussion S121. PubMed ID: 18086048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperdiluted Calcium Hydroxylapatite 1: 2 for Mid and Lower Facial Skin Rejuvenation: Efficacy and Safety.
    Rovatti PP; Pellacani G; Guida S
    Dermatol Surg; 2020 Dec; 46(12):e112-e117. PubMed ID: 32205749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.
    Daines SM; Williams EF
    JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen.
    Lapatina NG; Pavlenko T
    J Drugs Dermatol; 2017 Sep; 16(9):900-906. PubMed ID: 28915285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 52-week study of safety and efficacy of calcium hydroxylapatite for rejuvenation of the aging hand.
    Sadick NS
    J Drugs Dermatol; 2011 Jan; 10(1):47-51. PubMed ID: 21197523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CALCIUM HYDROXYLAPATITE MICROSPHERES - BIOCOMPATIBILITY AND CLINICAL EFFECTS.
    Wollina U; Wiegand C; Hipler UC
    Georgian Med News; 2018 May; (278):62-68. PubMed ID: 29905547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss.
    Muti GF
    J Drugs Dermatol; 2019 Jan; 18(1):86-91. PubMed ID: 30681803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot Study Examining the Safety and Efficacy of Calcium Hydroxylapatite Filler With Integral Lidocaine Over a 12-Month Period to Correct Temporal Fossa Volume Loss.
    Juhász MLW; Levin MK; Marmur ES
    Dermatol Surg; 2018 Jan; 44(1):93-100. PubMed ID: 28858938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.
    Moers-Carpi MM; Tufet JO
    Dermatol Surg; 2008 Feb; 34(2):210-5. PubMed ID: 18093199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The basic science of dermal fillers: past and present Part II: adverse effects.
    Gilbert E; Hui A; Meehan S; Waldorf HA
    J Drugs Dermatol; 2012 Sep; 11(9):1069-77. PubMed ID: 23135649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions.
    Alam M; Yoo SS
    J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review.
    Trinh LN; Gupta A
    Facial Plast Surg; 2021 Aug; 37(4):536-542. PubMed ID: 33648015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres.
    Roy D; Sadick N; Mangat D
    Dermatol Surg; 2006 Sep; 32(9):1134-9. PubMed ID: 16970693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.